申请人:Bayer Aktiengesellschaft
公开号:US05120782A1
公开(公告)日:1992-06-09
Substituted pyrrolo-pyridines can be prepared by reduction of the corresponding ketones. They are useful active compounds for medicaments and can be employed, for example, for the treatment of hyperlipoproteinaemia, lipoproteinaemia and arteriosclerosis.
取代的吡咯-吡啶可以通过还原相应的酮来制备。它们是有用的药物活性化合物,例如可用于治疗高脂蛋白血症、脂蛋白血症和动脉硬化。